Printer Friendly

Articles from M2 Pharma (June 6, 2019)

1-15 out of 15 article(s)
Title Author Type Words
Bavarian Nordic's ongoing phase 2 trial evaluating BN-Brachyury in chordoma shows positive results. 283
BRAINBox wins FDA's Breakthrough Device Designation for device to aid in concussion diagnosis. 278
Celgene Shows Data from Ongoing Studies of Liso-Cel in Patients with Difficult-to-Treat Blood Cancers at ASCO 2019. 864
Eiger BioPharmaceuticals names new vice president of Global Hepatitis Delta Virus Clinical Development. 297
EpimAb Biotherapeutics Raises USD 74m in Series B Financing. 473
Genentech Presents Pivotal Phase III CLL14 Results for Venclexta in Combination with Gazyva for Chronic Lymphocytic Leukemia. 115
GlucoMe collaborates with Roche. 169
Immunovant names new chief executive officer. 263
LPIXEL Starts AI System Development for Cell Evaluation with Astellas Pharma. 328
MA[pilcrow sign]lnlycke acquires patent to detect infected wounds. 189
MedTech Breakthrough honours Sorrel Medical. 194
Prevail Therapeutics IND Active for Phase 1/2 Trial of its Gene Therapy PR001 to Treat Parkinson's Disease Patients with GBA1Mutations. 337
Puma Biotechnology Presents Results from Phase III NALA Trial of Neratinib in Patients with HER2-Positive Metastatic Breast Cancer. 817
U Deliver Medical LLC gets FDA clearance for first tube feeding delivery system available over the counter. 151
Upsher-Smith Laboratories receives two Distribution Industry Awards by Healthcare Distribution Alliance. 157

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters